{
    "organizations": [],
    "uuid": "087e6aede0afa365d0acfe9ce9eba078630bb19c",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-edwards-granted-ce-mark-for-first/brief-edwards-granted-ce-mark-for-first-transcatheter-tricuspid-therapy-idUSFWN1S719T",
    "ord_in_thread": 0,
    "title": "BRIEF-Edwards Granted CE Mark For First Transcatheter Tricuspid Therapy",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 30 (Reuters) - Edwards Lifesciences Corp:\n* EDWARDS GRANTED CE MARK FOR FIRST TRANSCATHETER TRICUSPID THERAPY Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-05-01T05:05:00.000+03:00",
    "crawled": "2018-05-01T00:22:24.017+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "edward",
        "lifesciences",
        "corp",
        "edward",
        "granted",
        "ce",
        "mark",
        "first",
        "transcatheter",
        "tricuspid",
        "therapy",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}